143 related articles for article (PubMed ID: 21335489)
1. Genome-wide expression profiling identifies an impairment of negative feedback signals in the Crohn's disease-associated NOD2 variant L1007fsinsC.
Billmann-Born S; Till A; Arlt A; Lipinski S; Sina C; Latiano A; Annese V; Häsler R; Kerick M; Manke T; Seegert D; Hanidu A; Schäfer H; van Heel D; Li J; Schreiber S; Rosenstiel P
J Immunol; 2011 Apr; 186(7):4027-38. PubMed ID: 21335489
[TBL] [Abstract][Full Text] [Related]
2. MIP-3α expression in macrophages is NOD dependent.
Hausmann M; Zeitler C; Weber A; Krebs M; Kellermeier S; Rosenstiel P; de Vallière C; Kosovac K; Fried M; Holler E; Rogler G
Digestion; 2012; 85(3):192-201. PubMed ID: 22286692
[TBL] [Abstract][Full Text] [Related]
3. The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype.
Borm ME; van Bodegraven AA; Mulder CJ; Kraal G; Bouma G
Genes Immun; 2008 Apr; 9(3):274-8. PubMed ID: 18340358
[TBL] [Abstract][Full Text] [Related]
4. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.
Maeda S; Hsu LC; Liu H; Bankston LA; Iimura M; Kagnoff MF; Eckmann L; Karin M
Science; 2005 Feb; 307(5710):734-8. PubMed ID: 15692052
[TBL] [Abstract][Full Text] [Related]
5. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan.
Bonen DK; Ogura Y; Nicolae DL; Inohara N; Saab L; Tanabe T; Chen FF; Foster SJ; Duerr RH; Brant SR; Cho JH; Nuñez G
Gastroenterology; 2003 Jan; 124(1):140-6. PubMed ID: 12512038
[TBL] [Abstract][Full Text] [Related]
6. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.
Li J; Moran T; Swanson E; Julian C; Harris J; Bonen DK; Hedl M; Nicolae DL; Abraham C; Cho JH
Hum Mol Genet; 2004 Aug; 13(16):1715-25. PubMed ID: 15198989
[TBL] [Abstract][Full Text] [Related]
7. Identification of a synthetic muramyl peptide derivative with enhanced Nod2 stimulatory capacity.
Rubino SJ; Magalhaes JG; Philpott D; Bahr GM; Blanot D; Girardin SE
Innate Immun; 2013 Oct; 19(5):493-503. PubMed ID: 23339926
[TBL] [Abstract][Full Text] [Related]
8. The complex interplay of NOD-like receptors and the autophagy machinery in the pathophysiology of Crohn disease.
Billmann-Born S; Lipinski S; Böck J; Till A; Rosenstiel P; Schreiber S
Eur J Cell Biol; 2011; 90(6-7):593-602. PubMed ID: 21146253
[TBL] [Abstract][Full Text] [Related]
9. Innate immune sensing of microbes by Nod proteins.
Kufer TA; Banks DJ; Philpott DJ
Ann N Y Acad Sci; 2006 Aug; 1072():19-27. PubMed ID: 17057187
[TBL] [Abstract][Full Text] [Related]
10. Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop.
Begue B; Dumant C; Bambou JC; Beaulieu JF; Chamaillard M; Hugot JP; Goulet O; Schmitz J; Philpott DJ; Cerf-Bensussan N; Ruemmele FM
J Cell Physiol; 2006 Nov; 209(2):241-52. PubMed ID: 16897777
[TBL] [Abstract][Full Text] [Related]
11. Hyperexpression of NOD2 in intestinal mast cells of Crohn's disease patients: preferential expression of inflammatory cell-recruiting molecules via NOD2 in mast cells.
Okumura S; Yuki K; Kobayashi R; Okamura S; Ohmori K; Saito H; Ra C; Okayama Y
Clin Immunol; 2009 Feb; 130(2):175-85. PubMed ID: 18938111
[TBL] [Abstract][Full Text] [Related]
12. The protein Nod2: an innate receptor more complex than previously assumed.
Lecat A; Piette J; Legrand-Poels S
Biochem Pharmacol; 2010 Dec; 80(12):2021-31. PubMed ID: 20643110
[TBL] [Abstract][Full Text] [Related]
13. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL
Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
[TBL] [Abstract][Full Text] [Related]
14. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.
Netea MG; Kullberg BJ; de Jong DJ; Franke B; Sprong T; Naber TH; Drenth JP; Van der Meer JW
Eur J Immunol; 2004 Jul; 34(7):2052-9. PubMed ID: 15214053
[TBL] [Abstract][Full Text] [Related]
15. Towards an understanding of the role of NOD2/CARD15 in the pathogenesis of Crohn's disease.
Philpott DJ; Viala J
Best Pract Res Clin Gastroenterol; 2004 Jun; 18(3):555-68. PubMed ID: 15157827
[TBL] [Abstract][Full Text] [Related]
16. Nod2 improves barrier function of intestinal epithelial cells via enhancement of TLR responses.
Hiemstra IH; Bouma G; Geerts D; Kraal G; den Haan JM
Mol Immunol; 2012 Oct; 52(3-4):264-72. PubMed ID: 22750073
[TBL] [Abstract][Full Text] [Related]
17. CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease.
Peeters H; Bogaert S; Laukens D; Rottiers P; De Keyser F; Darfeuille-Michaud A; Glasser AL; Elewaut D; De Vos M
Int J Immunogenet; 2007 Jun; 34(3):181-91. PubMed ID: 17504508
[TBL] [Abstract][Full Text] [Related]
18. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease.
Peyrin-Biroulet L; Chamaillard M
J Endotoxin Res; 2007; 13(3):135-9. PubMed ID: 17621555
[TBL] [Abstract][Full Text] [Related]
19. Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL-1beta.
Ferwerda G; Kramer M; de Jong D; Piccini A; Joosten LA; Devesaginer I; Girardin SE; Adema GJ; van der Meer JW; Kullberg BJ; Rubartelli A; Netea MG
Eur J Immunol; 2008 Jan; 38(1):184-91. PubMed ID: 18157816
[TBL] [Abstract][Full Text] [Related]
20. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.
Ogura Y; Bonen DK; Inohara N; Nicolae DL; Chen FF; Ramos R; Britton H; Moran T; Karaliuskas R; Duerr RH; Achkar JP; Brant SR; Bayless TM; Kirschner BS; Hanauer SB; Nuñez G; Cho JH
Nature; 2001 May; 411(6837):603-6. PubMed ID: 11385577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]